A New Classification System for the Actions of IRS Chemicals Traditionally Used For Malaria Control

Knowledge of how mosquitoes respond to insecticides is of paramount importance in understanding how an insecticide functions to prevent disease transmission. A suite of laboratory assays was used to quantitatively characterize mosquito responses to toxic, contact irritant, and non-contact spatial repellent actions of standard insecticides. Highly replicated tests of these compounds over a range of concentrations proved that all were toxic, some were contact irritants, and even fewer were non-contact repellents. Of many chemicals tested, three were selected for testing in experimental huts to confirm that chemical actions documented in laboratory tests are also expressed in the field. The laboratory tests showed the primary action of DDT is repellent, alphacypermethrin is irritant, and dieldrin is only toxic. These tests were followed with hut studies in Thailand against marked-released populations. DDT exhibited a highly protective level of repellency that kept mosquitoes outside of huts. Alphacypermethrin did not keep mosquitoes out, but its strong irritant action caused them to prematurely exit the treated house. Dieldrin was highly toxic but showed no irritant or repellent action. Based on the combination of laboratory and confirmatory field data, we propose a new paradigm for classifying chemicals used for vector control according to how the chemicals actually function to prevent disease transmission inside houses. The new classification scheme will characterize chemicals on the basis of spatial repellent, contact irritant and toxic actions

Magnetic structure of greigite (Fe3S4) probed by neutron powder diffraction and polarized neutron diffraction

We have investigated greigite (Fe3S4) using a combination of neutron powder diffraction and polarized neutron diffraction to give the first unambiguous assignment of its magnetic structure. Our results confirm that greigite has a collinear ferrimagnetic structure with antiferromagnetic coupling between the tetrahedral (A) and octahedral (B) sites. Our analysis also indicates that greigite does not have a significant vacancy concentration or spin canting. High-resolution neutron powder diffraction results enable determination of sublattice magnetizations of the A and B sites. At room temperature, the average magnetic moments on the two sites are almost the same (?3.0 ? B), with a net magnetic moment of ?3.0 ? B per formula unit (fu). The magnetic moment of the B sites decreases slightly between 10 K and room temperature, while the A site moment is relatively stable as a function of temperature; this indicates that greigite is probably an R-type ferrimagnet. At 10 K, the average magnetic moments of the A and B sites are 3.0 ? B and 3.25 ? B, respectively. Neutron diffraction measurements, coupled with magnetic measurements, on our pure synthetic greigite samples indicate that the saturation magnetization of greigite is lower than that of magnetite (Fe3O4). It is proposed that the lower magnetic moment in greigite (saturation magnetization is ?59 A m2 kg?1) compared to magnetite is probably caused by an increased degree of covalency between iron and sulfur compared to oxygen ligands or by greater delocalization of the 3d electrons in greigite

PDGF-BB Does Not Accelerate Healing in Diabetic Mice with Splinted Skin Wounds

Topical application of platelet-derived growth factor-BB (PDGF-BB) is considered to accelerate tissue repair of impaired chronic wounds. However, the vast literature is plagued with conflicting reports of its efficacy in animal models and this is often influenced by a wide array of experimental variables making it difficult to compare the results across the studies. To mitigate the confounding variables that influence the efficacy of topically applied PDGF-BB, we used a controlled full thickness splinted excisional wound model in db/db mice (type 2 diabetic mouse model) for our investigations. A carefully-defined silicone-splinted wound model, with reduced wound contraction, controlled splint and bandage maintenance, allowing for healing primarily by reepithelialization was employed. Two splinted 8 mm dorsal full thickness wounds were made in db/db mice. Wounds were topically treated once daily with either 3 µg PDGF-BB in 30 µl of 5% PEG-PBS vehicle or an equal volume of vehicle for 10 days. Body weights, wound contraction, wound closure, reepithelialization, collagen content, and wound bed inflammation were evaluated clinically and histopathologically. The bioactivity of PDGF-BB was confirmed by in vitro proliferation assay. PDGF-BB, although bioactive in vitro, failed to accelerate wound healing in vivo in the db/db mice using the splinted wound model. Considering that the predominant mechanism of wound healing in humans is by re-epithelialization, the most appropriate model for evaluating therapeutics is one that uses splints to prevent excessive wound contraction. Here, we report that PDGF-BB does not promote wound closure by re-epithelialization in a murine splinted wound model. Our results highlight that the effects of cytoactive factors reported in vivo ought to be carefully interpreted with critical consideration of the wound model used